| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
REPRODUCTION-DEVELOPMENT |
Department of Animal Sciences (N.L., M.G., R.Ma., R.Me.), Faculty of Agricultural, Food and Environmental Quality Sciences, The Hebrew University of Jerusalem, Rehovot 76100, Israel; Howard Hughes Medical Institute and Department of Molecular Genetics (M.Y.), University of Texas, Southwestern Medical Center, Dallas, Texas 75235; and Department of Animal Sciences (M.F.S., J.H.H.), University of Missouri, Columbia, Missouri 65211
Address all correspondence and requests for reprints to: Rina Meidan, Department of Animal Sciences, Faculty of Agricultural, Food and Environmental Quality Sciences, The Hebrew University of Jerusalem, Rehovot 76100, Israel. E-mail: rina.meidan{at}huji.ac.il
Endothelin-1 (ET)-1 within the corpus luteum (CL) is rapidly
up-regulated during natural or PGF2
-induced luteolysis;
however, such an increase was not observed at early luteal stage, when
the CL is refractory to PGF2
. The mature and active form
of ET-1 is derived from the inactive intermediate peptide, big ET-1, by
ET-converting enzyme (ECE)-1. This study therefore examined the
developmental and cell-specific expression of ECE-1 in bovine CL. A
significant, 4-fold, elevation in ECE-1 expression (mRNA and protein
levels) occurred during the transition of the CL from early to
midluteal phase. Analysis using in-situ hybridization
and enriched luteal cell subpopulations showed that both steroidogenic
and endothelial cells of the CL expressed high levels of ECE-1 mRNA;
prepro ET-1 mRNA, on the other hand, was only expressed by resident
endothelial cells. These data suggest that luteal parenchymal and
endothelial cells may cooperate in the biosynthesis of mature bioactive
ET-1. In the mature CL, ECE-1 mRNA increase occurred both in
steroidogenic and endothelial cells and was accompanied by a
significant rise in ET-1 peptide. However, in contrast to ECE-1, prepro
ET-1 mRNA levels were similar in early and midluteal-phase CL. Low
ECE-1 levels during the early luteal phase, restricting the production
of active ET-1, may explain why the immature CL is able to withstand
PGF2
-induced luteolysis.
This article has been cited by other articles:
![]() |
M. J Cannon, J. S Davis, and J. L Pate The class II major histocompatibility complex molecule BoLA-DR is expressed by endothelial cells of the bovine corpus luteum Reproduction, May 1, 2007; 133(5): 991 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Townson Immune cell-endothelial cell interactions in the bovine corpus luteum Integr. Comp. Biol., December 1, 2006; 46(6): 1055 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rosiansky-Sultan, E. Klipper, K. Spanel-Borowski, and R. Meidan Inverse Relationship between Nitric Oxide Synthases and Endothelin-1 Synthesis in Bovine Corpus Luteum: Interactions at the Level of Luteal Endothelial Cell Endocrinology, November 1, 2006; 147(11): 5228 - 5235. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Klipper, N. Levy, T. Gilboa, L. Muller, and R. Meidan Identification of a novel alternatively spliced variant endothelin converting enzyme-1 lacking a transmembrane domain. Experimental Biology and Medicine, June 1, 2006; 231(6): 723 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Meidan, E. Klipper, T. Gilboa, L. Muller, and N. Levy Endothelin-converting Enzyme-1, Abundance of Isoforms a-d and Identification of a Novel Alternatively Spliced Variant Lacking a Transmembrane Domain J. Biol. Chem., December 9, 2005; 280(49): 40867 - 40874. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kisliouk, H. Podlovni, K. Spanel-Borowski, O. Ovadia, Q.-Y. Zhou, and R. Meidan Prokineticins (Endocrine Gland-Derived Vascular Endothelial Growth Factor and BV8) in the Bovine Ovary: Expression and Role as Mitogens and Survival Factors for Corpus Luteum-Derived Endothelial Cells Endocrinology, September 1, 2005; 146(9): 3950 - 3958. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sen, E. Choudhary, E. K. Inskeep, and J. A. Flores Effects of Selective Protein Kinase C Isozymes in Prostaglandin2{alpha}-Induced Ca2+ Signaling and Luteinizing Hormone-Induced Progesterone Accumulation in the Mid-Phase Bovine Corpus Luteum Biol Reprod, April 1, 2005; 72(4): 976 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Choudhary, A. Sen, E. K. Inskeep, and J. A. Flores Developmental Sensitivity of the Bovine Corpus Luteum to Prostaglandin F2{alpha} (PGF2{alpha}) and Endothelin-1 (ET-1): Is ET-1 a Mediator of the Luteolytic Actions of PGF2{alpha} or a Tonic Inhibitor of Progesterone Secretion? Biol Reprod, March 1, 2005; 72(3): 633 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Klipper, T. Gilboa, N. Levy, T. Kisliouk, K. Spanel-Borowski, and R. Meidan Characterization of endothelin-1 and nitric oxide generating systems in corpus luteum-derived endothelial cells Reproduction, October 1, 2004; 128(4): 463 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Ohtani, S Takase, M P B Wijayagunawardane, M Tetsuka, and A Miyamoto Local interaction of prostaglandin F2{alpha} with endothelin-1 and tumor necrosis factor-{alpha} on the release of progesterone and oxytocin in ovine corpora lutea in vivo: a possible implication for a luteolytic cascade Reproduction, January 1, 2004; 127(1): 117 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kisliouk, N. Levy, A. Hurwitz, and R. Meidan Presence and Regulation of Endocrine Gland Vascular Endothelial Growth Factor/Prokineticin-1 and Its Receptors in Ovarian Cells J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3700 - 3707. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Levy, M. Gordin, M. F. Smith, O. U. Bolden-Tiller, and R. Meidan Hormonal Regulation and Cell-Specific Expression of Endothelin-Converting Enzyme 1 Isoforms in Bovine Ovarian Endothelial and Steroidogenic Cells Biol Reprod, April 1, 2003; 68(4): 1361 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Funke-Kaiser, F. Reichenberger, K. Kopke, S.-M. Herrmann, J. Pfeifer, H.-D. Orzechowski, W. Zidek, M. Paul, and E. Brand Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation Hum. Mol. Genet., February 15, 2003; 12(4): 423 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Muller, A. Barret, E. Etienne, R. Meidan, O. Valdenaire, P. Corvol, and C. Tougard Heterodimerization of Endothelin-converting Enzyme-1 Isoforms Regulates the Subcellular Distribution of This Metalloprotease J. Biol. Chem., January 3, 2003; 278(1): 545 - 555. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |